The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis

30 June 2021 (14:00 - 15:00)
Organised by:
Congress Presentation Part of: Chronic Heart Failure - Pathophysiology and Mechanisms 2 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by